Full-Time

Software Developer

OTC Technology

Posted on 7/28/2025

XTX Markets

XTX Markets

201-500 employees

Electronic trading platform and market-making provider

No salary listed

London, UK

Hybrid

Hybrid role; 4 days in-office and 1 day remote per week.

Category
Software Engineering (3)
, ,
Required Skills
Kotlin
Java
C#
C/C++
Linux/Unix
Requirements
  • Is an experienced coder, with a solid understanding of Computer Science fundamentals.
  • Has several years of experience working in Kotlin or other object-oriented languages like Java, C++, or C#.
  • Knows how to build technology quickly and safely using a variety of testing methods.
  • Unblocks the team with code reviews that prioritise correctness over style preferences.
  • Has experience in systems with requirements of microseconds per request or gigabits per second per thread.
  • Has experience coding to Linux APIs: Our preferred development environment is IntelliJ on Linux.
Responsibilities
  • Architects, implements and maintains a diverse set of trading systems, including prop trading on venue and OTC liquidity provision platforms across asset class (primarily Equities, FX and Crypto).
  • Receives reference implementations of models from quants, hard control requirements from Risk and Compliance, and system ergonomics requests from Trading Analysts, often working closely with those teams to find the best direction.
  • Is highly autonomous in how we work, maximising safety and velocity.
  • Builds and maintains multiple trading systems with a fraction of the headcount of our competitors, so it's critical we can eliminate bureaucracy.
Desired Qualifications
  • Interested in financial markets but doesn't necessarily have professional experience.

XTX Markets provides liquidity and executes trades across multiple asset classes, serving institutional clients by acting as a global electronic market maker. It operates a high-technology trading platform that uses algorithms and high-frequency strategies to place and manage large buy and sell orders, delivering tight prices and deep liquidity by continuously analyzing market data and running quantitative models. The firm differentiates itself through a strong focus on transparency, ethical trading practices, data-driven decision making, and a client-centric approach that offers tailored support and long-term partnerships. Its goal is to strengthen market liquidity and stability by providing reliable, efficient, and well-priced trading solutions.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

2015

Simplify Jobs

Simplify's Take

What believers are saying

  • Revenues rose 44% to £3.9 billion in 2025 from market volatility.
  • Expanding into digital assets and DeFi with quantitative models.
  • Building data centre in Finland enhances computational resources.

What critics are saying

  • UK FCA and SEC target XTX's HFT with enforcement in 6-12 months.
  • Gerko's 75% ownership triggers crisis if he departs in 12-24 months.
  • Citadel poaches XTX's 250 quants within 6-12 months.

What makes XTX Markets unique

  • XTX Markets uses machine learning for price forecasts across 50,000 instruments.
  • Firm provides customized low-market-impact liquidity to institutional clients.
  • Trades $250 billion daily across 35 countries with no human traders.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Gym Membership

Health Insurance

Paid Holidays

401(k) Retirement Plan

Company News

Yahoo Finance
Apr 3rd, 2026
London's biggest taxpayer set for $866M+ payday as trading firm posts record $2.2B profit

XTX, the trading firm owned by London's biggest taxpayer Alex Gerko, posted record profits of £1.7 billion in 2025, up 33% from the previous year. Revenues rose 44% to £3.9 billion as the company capitalised on market volatility. Gerko, who owns 75% of XTX, paid himself £682 million last year and paid £331.4 million in personal tax, making him London's highest taxpayer. The Russian-born British citizen founded XTX in 2015 and has grown it into one of Britain's most profitable companies using machine learning technology to handle over $250 billion in daily transactions. The 46-year-old mathematician has donated more than £350 million to charities since 2020, focusing on mathematics education and conservation efforts.

TechRound
Mar 30th, 2026
Lucida Medical Raises £8.7 Million To Supercharge Same-Day AI Cancer Diagnosis - TechRound

Lucida Medical raises £8.7m to expand its AI-powered same-day cancer diagnosis platform, speeding up detection and supporting earlier treatment.

PR Newswire
Mar 4th, 2026
Crossover Markets raises $31M at $200M valuation in Tradeweb-led Series B round

Crossover Markets has raised $31 million in a Series B round led by Tradeweb Markets, valuing the institutional digital asset trading firm at $200 million. DRW Venture Capital, Illuminate Financial, Ripple, Virtu Financial, Wintermute Ventures and XTX Markets also participated. The company operates CROSSx, one of the industry's first execution-only cryptocurrency electronic communication networks. Since launch, CROSSx has matched over $50 billion in notional trading volume across 12 million trades and supports nearly 100 live participants. Tradeweb plans to provide its global clients access to Crossover's institutional spot crypto liquidity through its algorithmic order-routing technology. The funding will enhance CROSSx's technology stack, expand global operations and deepen integrations with institutional partners. Crossover Markets is headquartered in Wilmington, Delaware.

Techcelerate Ltd (t/a Deal Lite)
Jan 27th, 2026
SOLVE Chemistry raises £4M led by XTX Ventures to accelerate chemical R&D with AI

SOLVE Chemistry, a London-based AI startup, has raised £4 million in seed funding led by XTX Ventures, with participation from SuperSeed, Creator Fund and Endgame Capital. The Imperial College London spinout uses ultra-high-throughput data collection hardware to obtain chemical reaction data 20 times faster than traditional methods, training AI models to predict optimal manufacturing processes. The company works with pharmaceutical and agrochemical manufacturers, including BASF and multinational pharmaceutical firms, to accelerate production timelines and reduce costs. The funding will enable SOLVE Chemistry to quadruple production capacity and expand its team. Founded in April 2024 by Dr Linden Schrecker and Dr Jose Pablo Folch, the company completed its spinout from Imperial in just one month, significantly faster than the typical six-month timeline for university spinouts.

Tech.eu
Dec 3rd, 2025
Mater-AI secures £1.5M to tackle one of energy’s oldest problems: wasted heat

By targeting an overlooked gap in thermoelectrics, Mater-AI unlocked a rapid series of investments long before most deeptech teams reach traction.

INACTIVE